300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance
The GAVI global vaccine alliance said on Friday some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large-scale outbreak, after the World Health Organization confirmed a fatal case in Congo.
The vaccine, known as rVSV-ZEBOV, was shown to be highly protective against Ebola in clinical trials published last December.
A spokesman for the World Health Organization told Reuters on Friday that a person in the Democratic Republic of Congo had died after becoming infected with Ebola - a contagious virus that causes hemorrhagic fever.
(Reporting by Kate Kelland; Editing by Hugh Lawson)
The vaccine, known as rVSV-ZEBOV, was shown to be highly protective against Ebola in clinical trials published last December.
A spokesman for the World Health Organization told Reuters on Friday that a person in the Democratic Republic of Congo had died after becoming infected with Ebola - a contagious virus that causes hemorrhagic fever.
(Reporting by Kate Kelland; Editing by Hugh Lawson)
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd